Evidence map›Paper›PMID 38651799›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2024

Combined effect of time in target range and variability of systolic blood pressure on cardiovascular outcomes and mortality in patients with hypertension: A prospective cohort study.

Zekun Feng, Yanjie Li, Chi Wang, Lu Tian, Siyu Yao, Miao Wang, Maoxiang Zhao, Lihua Lan, Shouling Wu, Hao Xue

Abstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zekun FengDepartment of Cardiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
Yanjie LiSchool of Medicine, Nankai University, Tianjin, China.
Chi WangDepartment of Cardiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
Lu TianSchool of Medicine, Nankai University, Tianjin, China.
Siyu YaoDepartment of Cardiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
Miao WangSchool of Medicine, Nankai University, Tianjin, China.
Maoxiang ZhaoDepartment of Cardiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.ORCID 0000-0001-7027-5913
Lihua LanSchool of Medicine, Nankai University, Tianjin, China.
Shouling WuDepartment of Cardiology, Kailuan General Hospital, Tangshan, China.
Hao XueDepartment of Cardiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.ORCID 0000-0001-5915-4811

Funding

The Capital Health Research and Development of Special Fund, Beijing Health Commission 2020-2-5013
6 · The paper itself

Abstract

Time in target range (TTR) and blood pressure variability (BPV) of systolic blood pressure (SBP) are independent risk factors for major adverse cardiovascular events (MACE) and all-cause mortality in hypertensive patients. However, the association of the combination of low TTR and high BPV of SBP with the risk of MACE and all-cause mortality is unclear. This study sought to investigate the combined effect of the TTR and BPV on the risk of MACE and all-cause mortality in patients with hypertension. A total of 11 496 hypertensive patients from the Kailuan cohort study were included in our study. All participants were divided into four groups according to their TTR and BPV levels. Cox proportional hazards regression models were used to calculate the hazard ratios (HRs) and 95% confidence interval (CI) for incident MACE and all-cause mortality. During a median follow-up of 5.64 years, 839 MACEs (included 99 cases of myocardial infarction, 591 cases of stroke, and 191 cases of heart failure) and 621 deaths occurred. Compared with the high-TTR and low-BPV group, the HRs (95% CI) of MACE and all-cause mortality were 1.309 (1.025-1.671) and 1.842 (1.373-2.473) for the high-TTR and high-BPV group, 1.692 (1.347-2.125) and 1.731 (1.298-2.309) for the low-TTR & low-BPV group, 2.132 (1.728-2.629) and 2.247 (1.722-2.932) for the low-TTR & high-BPV group. Our study suggests that the combination of low TTR and high BPV of SBP was associated with a higher risk of MACE and all-cause mortality in patients with hypertension.

Indexed as

Blood PressureHypertensionAgedAntihypertensive AgentsBlood Pressure DeterminationCardiovascular DiseasesCause of DeathChinaFemaleHeart FailureHumansMaleMiddle AgedMyocardial InfarctionProportional Hazards ModelsProspective StudiesAntihypertensive Agents

Identifiers

PMID38651799
PMCPMC11180674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.